Compare SOUN & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SOUN | ITGR |
|---|---|---|
| Founded | 2005 | 1970 |
| Country | United States | United States |
| Employees | 954 | N/A |
| Industry | EDP Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.1B |
| IPO Year | N/A | 2000 |
| Metric | SOUN | ITGR |
|---|---|---|
| Price | $6.52 | $95.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | $15.00 | ★ $91.14 |
| AVG Volume (30 Days) | ★ 25.4M | 430.5K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.48 |
| Revenue | N/A | ★ $1,853,637,000.00 |
| Revenue This Year | $40.76 | $1.69 |
| Revenue Next Year | $20.02 | $6.53 |
| P/E Ratio | ★ N/A | $194.14 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $5.83 | $62.00 |
| 52 Week High | $22.17 | $117.58 |
| Indicator | SOUN | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 42.60 | 57.42 |
| Support Level | $6.04 | $82.58 |
| Resistance Level | $7.09 | $95.48 |
| Average True Range (ATR) | 0.41 | 2.72 |
| MACD | 0.05 | 0.13 |
| Stochastic Oscillator | 44.17 | 82.37 |
SoundHound AI Inc is an innovator of conversational intelligence, offering an independent Voice AI platform that enables businesses across industries to deliver high-quality conversational experiences to customers. The company's voice AI delivers speed and accuracy in numerous languages to product creators and service providers across retail, financial services, healthcare, automotive, smart devices, and restaurants via groundbreaking AI-driven products like Smart Answering, Smart Ordering, Dynamic Drive-Thru, and Amelia AI Agents.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.